Tetrahydrobiopterin - Regulator of endothelial nitric oxide synthase in vascular disease

被引:152
作者
Channon, KM [1 ]
机构
[1] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
D O I
10.1016/j.tcm.2004.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In vascular disease states such as atherosclerosis and diabetes, endothelial nitric oxide (NO) bioactivity is reduced and oxidative stress is increased, resulting in endothelial dysfunction. Recent studies suggest that changes in the activity and regulation of endothelial NO synthase by its cofactor tetrahydrobiopterin (BH4) is an important contributor to endothelial dysfunction. Pharmacologic studies and more recent insights from genetically modified mouse models have improved the understanding of the mechanistic role and importance of BH4 in vascular disease pathogenesis. Targeting BH4 may provide new therapeutic strategies in vascular disease. (C) 2004, Elsevier Inc.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 31 条
[1]   Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease [J].
Alp, NJ ;
Channon, KM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :413-420
[2]   Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice [J].
Alp, NJ ;
McAteer, MA ;
Khoo, J ;
Choudhury, RP ;
Channon, KM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :445-450
[3]   Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression [J].
Alp, NJ ;
Mussa, S ;
Khoo, J ;
Cai, SJ ;
Guzik, T ;
Jefferson, A ;
Goh, N ;
Rockett, KA ;
Channon, KM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :725-735
[4]   GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation [J].
Cai, S ;
Alp, NJ ;
McDonald, D ;
Smith, I ;
Kay, J ;
Canevari, L ;
Heales, S ;
Channon, KM .
CARDIOVASCULAR RESEARCH, 2002, 55 (04) :838-849
[5]   Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice [J].
Cosentino, F ;
Barker, JE ;
Brand, MP ;
Heales, SJ ;
Werner, ER ;
Tippins, JR ;
West, N ;
Channon, KM ;
Volpe, M ;
Lüscher, TF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :496-502
[6]   Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity [J].
d'Uscio, LV ;
Milstien, S ;
Richardson, D ;
Smith, L ;
Katusic, ZS .
CIRCULATION RESEARCH, 2003, 92 (01) :88-95
[7]   Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase [J].
Fleming, I ;
Busse, R .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 284 (01) :R1-R12
[8]   Mechanisms of increased vascular superoxide production in human diabetes mellitus Role of NAD(P)H oxidase and endothelial nitric oxide synthase [J].
Guzik, TJ ;
Mussa, S ;
Gastaldi, D ;
Sadowski, J ;
Ratnatunga, C ;
Pillai, R ;
Channon, KM .
CIRCULATION, 2002, 105 (14) :1656-1662
[9]   HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells [J].
Hattori, Y ;
Nakanishi, N ;
Akimoto, K ;
Yoshida, M ;
Kasai, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :176-182
[10]   GTP cyclohydrolase I mRNA induction and tetrahydrobiopterin synthesis in human endothelial cells [J].
Hattori, Y ;
Nakanishi, N ;
Kasai, K ;
Shimoda, SI .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1358 (01) :61-66